FindTrial
Sign In

Preoperative and postoperative immunity assessment of papillary thyroid carcinoma

Preoperative and postoperative immunity assessment of papillary thyroid carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046628
Enrollment
Unknown
Registered
2021-05-23
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary thyroid carcinoma

Interventions

PTC patient group VS normal person group:none

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who received surgical treatment for papillary thyroid carcinoma confirmed by preoperative fine or coarse needle puncture cytology or histology at West China Hospital of Sichuan University.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
T and B cell surface antigen receptors;—

Countries

China

Contacts

Public ContactLi Zhihui

West China Hospital of Sichuan University

rockoliver@163.com+86 18980602027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026